Oncowitan discloses a new publication, to highlight the anticancer potential of the well-established antibacterial drug nifuroxazide:
Bailly, C. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment, Drug Discovery Today (2019)
